跳至主要内容
临床试验/NCT04423198
NCT04423198Unknown不适用

HEAD Injury Serum Markers and Multi-modalities for Assessing Response to Trauma II

BRAINBox Solutions Inc11 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2020年12月31日最近更新:
适应症

试验速览

阶段
不适用
入组人数
2,000
试验地点
11
主要终点
Correlation of mild traumatic brain injury diagnosis using the BRAINBox TBI Test compared to the Expert Clinical Diagnosis

研究概览

简要总结

The goal of HeadSMART II (HEAD injury Serum markers and Multi-modalities for Assessing Response to Trauma II) is to develop an In-Vitro Diagnostic, the BRAINBox TBI test, to aid in the diagnosis and prognosis of patients with mild traumatic brain injury, by incorporating blood biomarkers, clinical assessments, and tools to measure associated neurocognitive impairments.

详细描述

This study proposes to collect data using a multi-modality approach including blood biomarkers, clinical assessments, neurocognitive performance, and neuropsychological characteristics, to identify subjects with a mild Traumatic Brain Injury (TBI) and their likelihood of chronic symptoms.

This is an observational study with an expectation of enrolling up to 2000 subjects. These subjects will include the intended use population, subjects presenting to the Emergency Department or Urgent Care with a blunt head trauma. Data will be collected across four time points, T=0, 14 days, 30 days and 90 days, to allow for building and validating the algorithms for both diagnosis and prognosis claims.

Control populations, healthy and trauma only (no head trauma) will be included for assay development. Data will be collected for these groups at T=0 and 14 days (trauma control only).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >=18 years
  • Ability to provide a blood sample; within 96 hours of injury
  • Ability to provide informed consent. Consent may be obtained with assistance of a legally authorized representative (LAR)
  • Must present to the Emergency Department (ED) or Urgent Care (UC) with a blunt head trauma

排除标准

  • Glasgow Coma Scale (GCS) score < 13, as presented in ED at time of screening
  • Need for general anesthesia at the time of presentation in the ED
  • Diagnosed dementia requiring assistance for daily living
  • Any head trauma requiring medical attention from a physician within the last 6 months
  • Received chemotherapy or radiation within the last year
  • History of stroke with disabling outcomes, brain tumor, epilepsy or intracranial surgery/hemorrhage
  • Psychiatric hospitalization in the last 90 days
  • Blood transfusion within the prior 4 weeks
  • Non-working telephone number
  • Current participant in an interventional clinical trial
  • Cannot perform study tasks on an iPad (e.g. not wearing corrective lenses necessary to read, inability to use both hands)
  • Subject considered unsuitable for participation in this clinical trial by PI, treating clinician or research study staff
  • Control Subjects
  • Age >=18 years
  • Ability to provide a blood sample; (For Trauma Controls (TC's) within 96 hours of injury)
  • Ability to provide informed consent. (For TC's consent may be obtained with assistance of a legally authorized representative (LAR)
  • Presents to the Emergency Department or Urgent Care with at least one injury requiring an X-Ray (TC's only)
  • Healthy and not taking prescription medications (Healthy Controls (HC's) only)
  • Head trauma or symptoms with head trauma at presentation
  • Head trauma requiring medical attention from a physician within the last 6 months
  • Internal organ injury (e.g. liver laceration, pulmonary contusion, spinal cord injury) that requires inpatient hospitalization
  • Need for general anesthesia at the time of presentation in the ED
  • Diagnosed dementia requiring assistance for daily living
  • Received chemotherapy or radiation within the last year
  • History of stroke with disabling outcomes, brain tumor, epilepsy or intracranial surgery/hemorrhage
  • Psychiatric hospitalization in the last 90 days
  • Blood transfusion within the prior 4 weeks
  • Non-working telephone number
  • Current participant in an interventional clinical trial
  • Cannot perform study tasks on an iPad (e.g. not wearing corrective lenses necessary to read, inability to use both hands)
  • Subject considered unsuitable for participation in this clinical trial by PI, treating clinician or research study staff

结局指标

主要结局

Correlation of mild traumatic brain injury diagnosis using the BRAINBox TBI Test compared to the Expert Clinical Diagnosis

时间窗: 30 days

Sensitivity and specificity of the diagnosis as compared to a clinical diagnosis by an expert committee

Determine the risk stratification of having symptoms at 14, 30 and 90 days, for subjects with mild traumatic brain injury using the BRAINBox TBI Test results.

时间窗: up to 90 days

Sensitivity and specificity of the risk for chronic symptoms as compared to the post-concussion symptoms at predefined time points

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (11)

Loading locations...

相似试验

HEAD Injury Serum Markers and Multi-modalities for... | 临床试验